FARMAE S.P.A. risk profile
35 Normal where most of the sector sits
Measured 1 September 2026 from U5Y's filed statements. Recomputed nightly.
35 (Normal), driven by Leverage and coverage at 97, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 36 | Normal | Stable | Average daily turnover — $14 |
| Operating pressure | 36 | Normal | Easing | Operating-margin drift — -1.9 percentage points |
| Cash conversion | 66 | Stretched | Easing | Capital spending against operating cash — 0.88x |
| Leverage and coverage | 97 | Acute | Stable | Net debt to EBITDA — 12.26x |
| Competitive position | 7 | Contained | Stable | Revenue-growth gap against peers — +45.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.